Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments

NCT01994031 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Paclitaxel liposome injection
DRUG: Paclitaxel injection

Sponsor

Nanjing Luye Sike Pharmaceutical Co., Ltd.